1. Home
  2. AKR vs VKTX Comparison

AKR vs VKTX Comparison

Compare AKR & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKR
  • VKTX
  • Stock Information
  • Founded
  • AKR 1993
  • VKTX 2012
  • Country
  • AKR United States
  • VKTX United States
  • Employees
  • AKR N/A
  • VKTX N/A
  • Industry
  • AKR Real Estate Investment Trusts
  • VKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AKR Real Estate
  • VKTX Health Care
  • Exchange
  • AKR Nasdaq
  • VKTX Nasdaq
  • Market Cap
  • AKR 2.9B
  • VKTX 3.4B
  • IPO Year
  • AKR 1993
  • VKTX 2015
  • Fundamental
  • Price
  • AKR $22.76
  • VKTX $34.07
  • Analyst Decision
  • AKR Buy
  • VKTX Strong Buy
  • Analyst Count
  • AKR 4
  • VKTX 14
  • Target Price
  • AKR $23.00
  • VKTX $97.29
  • AVG Volume (30 Days)
  • AKR 923.2K
  • VKTX 4.8M
  • Earning Date
  • AKR 02-11-2025
  • VKTX 02-05-2025
  • Dividend Yield
  • AKR 3.36%
  • VKTX N/A
  • EPS Growth
  • AKR N/A
  • VKTX N/A
  • EPS
  • AKR 0.19
  • VKTX N/A
  • Revenue
  • AKR $375,840,000.00
  • VKTX N/A
  • Revenue This Year
  • AKR N/A
  • VKTX N/A
  • Revenue Next Year
  • AKR $23.14
  • VKTX $986.87
  • P/E Ratio
  • AKR $119.75
  • VKTX N/A
  • Revenue Growth
  • AKR 13.25
  • VKTX N/A
  • 52 Week Low
  • AKR $16.10
  • VKTX $28.64
  • 52 Week High
  • AKR $26.29
  • VKTX $99.41
  • Technical
  • Relative Strength Index (RSI)
  • AKR 42.91
  • VKTX 51.41
  • Support Level
  • AKR $23.11
  • VKTX $28.90
  • Resistance Level
  • AKR $24.15
  • VKTX $34.37
  • Average True Range (ATR)
  • AKR 0.65
  • VKTX 2.37
  • MACD
  • AKR -0.03
  • VKTX 0.66
  • Stochastic Oscillator
  • AKR 11.69
  • VKTX 70.06

About AKR Acadia Realty Trust

Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company's portfolios are located primarily in metropolitan areas of the United States. The company operates through three segments: core portfolio, which consists primarily of high-quality retail properties located primarily in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon and generates the majority of total revenue; funds, which comprises the funds launched by the trust; and structured financing, which consists of notes receivable and related interest income.

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: